Regulatory delays could hinder Mind Medicine's patient access and market entry. Read why we are initiating coverage on MNMD ...

An interdisciplinary team comprising faculty and doctoral students from the Department of Anthropology and Computer Science ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...